Overview

Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19

Status:
Recruiting

Trial end date:
2020-09-30

Target enrollment:

Participant gender:

Summary

Currently there are no US Food and Drug Administration (FDA)-approved drugs specifically for the treatment of patients with COVID-19. At present, clinical management includes infection prevention and control measures, as well as supportive care, including supplementary oxygen and mechanical ventilatory support when indicated. An array of drugs approved for other indications as well as several investigational drugs are being studied in several hundred clinical trials that are underway across the globe; however, currently there are no clinical trials available to patients in Arizona. This study will determine if a specific drug cocktail can improve clinical outcomes in patients with confirmed Mild SARS-CoV-2

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Perseverance Research Center, LLC

Collaborator:

Athena Medical Group

Treatments:

Azithromycin
Hydroxychloroquine
Indomethacin